← HB766 bill details

Substantive final action

HB766

Senate Vote on HB 766 FINAL PASSAGE (#1341)

Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)

Passed Senate May 26, 2026⭐ Substantive final action

37Yea
0Nay
0Not voting
2Absent
Source provenance